ASH12: Anthracylcines May Not Be Needed in Pediatric Leukemia Induction

Share it with your friends Like

Thanks! Share it with your friends!


Children with standard-risk B-lineage acute lymphoblastic leukemia can be safely spared from at least some of the toxicity associated with anthracyclines, according to data presented at the American Society of Hematology. Neil Osterweil interviews Dr. Andre Baruchel, one of the study’s investigators. For ongoing ASH coverage, visit


Write a comment